University of Illinois at Chicago
Announcement of an Exempt Purchase
Vendor: ASD Healthcare, Frisco, TX
Amount: An estimated $10,000,000
An estimated start date of 9/11/2020 through 9/10/2025
The University award process may be delayed up to thirty days as this award goes through a state approval process.
First published Friday, September 11, 2020
The University awarded a contract for Gattex injections.
Gattex injection for bowel surgery patients.
This purchase is exempt from the usual selection processes of the Procurement Code because the procurement expenditure is for medical supplies or medical services necessary for the delivery of care and treatment at medical, dental, or veterinary teaching facilities utilized by SIU or U of I (30 ILCS 500 / 1-13(b-5)) For the continuum of care for the UI Health bowel surgery patients. Gattex is a GLP-2 analog for patients with Short Bowel Syndrome. Gattex improves intestinal absorption of nutrients for SBS patients, and allows them to be less dependent on Parenteral support (IV nutrition). Gattex is FDA approved, under patent, and only available from ASD.
For instructions on how to obtain a comprehensive purchase description, disclosure or contract forms, contact:
The State of Illinois has a policy to encourage prospective vendors to hire
qualified veterans, minorities, females, persons with disabilities and ex-offenders.